Table 4.
Model | Positive Symptoms | Negative Symptoms | Cognitive Symptoms | Progress of Schizophrenia | Role of Proteins | Time-Consuming | The Degree of Difficulty in Making the Model | Expense |
---|---|---|---|---|---|---|---|---|
Amphetamine model | + | − | + | − | − | − | low | low |
6-OHDA model | − | + | + | + | − | + | high | low |
DOI model | + | − | + | − | − | − | low | low |
PCP model | + | + | + | − | − | − | low | low |
Ketamine model | + | + | + | − | − | − | low | low |
MK-801 model | + | + | + | − | − | − | low | low |
DISC-1 model | − | + | + | − | + | + | high | high |
22q11.2 deletion | + | + | + | − | + | + | high | high |
Dysbindin-1 model | − | + | + | − | + | + | high | high |
NGR1 model | + | − | + | − | + | + | high | high |
NVHL model | + | + | + | + | − | + | high | low |
MIA model | + | + | + | + | − | + | low | low |
MAM model | + | + | + | + | − | + | low | low |